Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination

Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination

We retrospectively analyzed SARS-CoV-2 vaccination antibody responses in a cohort of 273 patients with lymphoproliferative disorders or plasma cell dyscrasias who were seen at a single tertiary cancer center. Semi-quantitative anti-spike protein serologic testing was performed with enzyme immunoassa...

Full description

Bibliographic Details
Main Authors:	Carol Gung, Regina McGuire, Mercy George, Abdullateef Abdulkareem, Katherine A. Belden, Pierluigi Porcu, Ubaldo Martinez-Outschoorn, Adam F. Binder, Inna Chervenova, Onder Alpdogan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Oncology
Subjects:	vaccination Covid-19 immune response hematologic malignancies chemotherapy.
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.840451/full

Similar Items

COVID-19 vaccine immune response and plasma cell dyscrasia
by: Amnuay Kleebayoon, et al.
Published: (2023-11-01)

Prevalence of Oral and Craniofacial Manifestations of Hematological Dyscrasias at Shiraz Nemazee Hospital
by: Janan Ghapanchi, et al.
Published: (2014-07-01)

Utility of CD200 expression by flow cytometry in lymphoproliferative disorders and plasma cell dyscrasias
by: Pavuluri Divya, et al.
Published: (2023-01-01)

COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
by: Unaiza Faizan, et al.
Published: (2023-08-01)

ROLE OF SERUM EOSINOPHILIC CATIONIC PROTEIN AND TRYPTASE IN MYELOPROLIFERATIVE AND LYMPHOPROLIFERATIVE DISORDERS
by: L. S. Komarova, et al.
Published: (2014-07-01)

Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
by: Sara Pasquina Pascale, et al.
Published: (2022-08-01)

Implementation of an Outpatient HD-MTX Initiative
by: Kelsey Sokol, et al.
Published: (2022-01-01)

The unfolded protein response links ER stress to cancer-associated thrombosis
by: Oluwatoyosi Muse, et al.
Published: (2023-10-01)

The fundus findings in blood dyscrasias
by: Kataria V, et al.
Published: (1983-12-01)

Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
by: Tomotaka Suzuki, et al.
Published: (2023-06-01)

ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genes
by: Marlie H. Fisher, et al.
Published: (2020-09-01)

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions
by: G. R. Hachatryan, et al.
Published: (2019-01-01)

Antiviral response and HIV-1 inhibition in sickle cell disease
by: Namita Kumari, et al.
Published: (2024-02-01)

COVID-19 vaccines and their potential use in patients with hematological malignancies
by: Ashraf Dada, et al.
Published: (2021-01-01)

Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies
by: Fernando Augusto Siqueira Mathias, et al.
Published: (2025-01-01)

INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY
by: Giuseppe La Torre
Published: (2016-09-01)

Rheumatic masks of plasma cell dyscrasias
by: Vladimir Ivanovich Vasilyev, et al.
Published: (2012-04-01)

Seasonal influenza vaccine in immunocompromised persons
by: Mohammad Bosaeed, et al.
Published: (2018-06-01)

Efficacy of intra-articular injection of allogeneic platelet-rich plasma for knee osteoarthritis combined with hematologic blood dyscrasias with platelet dysfunction: protocol of a randomized, double-blind, placebo-controlled trial
by: Xiaohang Zhu, et al.
Published: (2022-12-01)

Dendritic Cell Cancer Vaccines: From the Bench to the Bedside
by: Tamar Katz, et al.
Published: (2014-10-01)

Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
by: Laura Gleason, et al.
Published: (2022-12-01)

Effectiveness of using probiotic Batcinel-K® and CEVAC SET-K® vaccine on some blood parameters in chickens
by: Aamer R. Al-Aqaby, et al.
Published: (2021-08-01)

Effect of adding crushed Pimpinella anisum, Nigella sativa seeds and Thymus vulgaris mixture to antibiotics-free rations of vaccinated and non-vaccinated male broilers on growth performance, antibody titer and haematological profile
by: Mamoun Z. Athamneh, et al.
Published: (2010-04-01)

Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies
by: Michael A. Thompson, et al.
Published: (2022-07-01)

Exploring cutaneous lymphoproliferative disorders in the wake of COVID‐19 vaccination
by: Emily R. Gordon, et al.
Published: (2024-06-01)

Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
by: Christopher W. Dukes, et al.
Published: (2023-12-01)

Vaccination coverage among paediatric onco-haematological patients: an Italian cross-sectional study
by: Paola Giordano, et al.
Published: (2021-03-01)

A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
by: Zübeyde Nur Özkurt, et al.
Published: (2016-08-01)

Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response
by: Krischan Braitsch, et al.
Published: (2024-08-01)

Effect of COVID-19 and Its Vaccine: Hematological and Immunological Study of Recovered Individuals Based on Gender
by: Sulaf Adil Chyad, et al.
Published: (2024-07-01)

Effect of menthol and eugenol on the physiological responses of pacu Piaractus mesopotamicus
by: Milena Souza dos Santos Sanchez, et al.
Published: (2014-09-01)

Adherence to Sars-CoV2 vaccination in hematological patients
by: Justine Narinx, et al.
Published: (2022-10-01)

Real-world vaccination status of children with hematologic tumors before and after chemotherapy
by: Chai Ji, et al.
Published: (2023-12-01)

Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation
by: Jingjing Wang, et al.
Published: (2022-02-01)

COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
by: Luigi Cavanna, et al.
Published: (2021-09-01)

Keratoderma-Like T-Cell Dyscrasia: A Case Report
by: Asem Shadid, et al.
Published: (2024-10-01)

Retinopathy and vision-related quality of life in blood dyscrasias
by: Lipa Mohanty, et al.
Published: (2025-01-01)

Differential diagnosis of plasma cell dyscrasias in rheumatological practice
by: V I Vasilyev, et al.
Published: (2010-12-01)

Imaging for Plasma Cell Dyscrasias: What, When, and How?
by: Amrita Guha, et al.
Published: (2022-03-01)

Differential diagnosis of plasma cell dyscrasias in rheumatological practice
by: V I Vasilyev, et al.
Published: (2010-12-01)